483
UCLA Biomedical CyclotronUCLA Biomedical Cyclotron – FDA 483, Jul 31, 2025
Record Details
An FDA inspection of UCLA Biomedical Cyclotron in Los Angeles, a PET drug manufacturer, revealed significant deficiencies. The firm failed to approve processes before implementation, specifically regarding media fill simulations that did not reflect actual production. Additionally, the quality of microbiological media used in testing was not adequately controlled, and required testing on finished PET drug products was not performed before release.
View Company Profile
ID · 3eb814fe-3b8c-4da9-adfc-f9e4b47ec923
Other documents for UCLA Biomedical Cyclotron
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.